Tag Archives: CAR-T therapy

Novartis to Present Late-Breaking Phase III Data on Ianalumab and New CAR-T Insights at ACR 2025, Advancing Leadership in Autoimmune Disease Research

(IN BRIEF) Novartis will present new data from 27 abstracts at the 2025 American College of Rheumatology (ACR) Convergence, featuring late-breaking Phase III results from the NEPTUNUS-1 and NEPTUNUS-2 trials of ianalumab in Sjögren’s disease, which could become the first … Read the full press release

Europe’s RNA Immunotherapy Enters a New Phase: Trials Scale Up, Deals Consolidate, and Regulators Move

Europe’s RNA immunotherapy sector is gaining speed with new in vivo CAR-T and mRNA vaccine trials. Germany approved the region’s first in vivo CAR-T study, marking regulatory progress. The UK’s Cancer Vaccine Launch Pad advances personalised mRNA cancer vaccine trials … Read the full press release